World’s First Experience Treating TASC II C and D Tibial Occlusive Disease Using the Selution SLR Sirolimus-Eluting Balloon: Six-Month Results From the PRESTIGE Study

PURPOSE: The performance of sirolimus-coated devices has not been studied in patients with chronic limb-threatening ischemia patients. PRESTIGE aims to investigate the 6-month efficacy and safety profile of the Selution Sustained Limus Release (SLR) sirolimus-eluting balloon for treatment of TASC II...

Descripción completa

Detalles Bibliográficos
Autores principales: Tang, Tjun Yip, Yap, Charyl, Soon, Shereen Xue Yun, Chan, Sze Ling, Lee, QingWei Shaun, Yap, Hao Yun, Tay, Hsien Ts’ung Luke, Chong, Tze Tec
Formato: Online Artículo Texto
Lenguaje:English
Publicado: SAGE Publications 2021
Materias:
Clinical Investigations
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8276341/
https://www.ncbi.nlm.nih.gov/pubmed/33843364
http://dx.doi.org/10.1177/15266028211007457

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8276341/
https://www.ncbi.nlm.nih.gov/pubmed/33843364
http://dx.doi.org/10.1177/15266028211007457

Ejemplares similares